Opaleye Management Inc.'s Form 4 filing
Tracon Pharmaceuticals, Inc. (TCON) · filed Dec 7, 2021
- Accession no.
- 0001493152-21-030696
- Filed
- Dec 7, 2021
- Trade date
- Dec 3-6, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $256.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +80,000 | $2.30 | +$184,000 | 2,428,371 | Indirect | |
| Dec 3, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +9,274 | $2.30 | +$21,330.2 | 239,774 | Indirect | |
| Dec 6, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +20,000 | $2.26 | +$45,200 | 2,448,371 | Indirect | |
| Dec 6, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,733 | $2.26 | +$6,176.58 | 242,507 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.